The China Continuous Glucose Monitoring Devices Market Is Estimated To Witness High Growth Owing To Rising Prevalence of Diabetes and Technological Advancements
China Continuous Glucose Monitoring Devices Market |
Market Overview:
Continuous glucose monitoring devices help in
monitoring real-time glucose levels in interstitial fluid or blood of diabetic
patients. They provide frequent glucose readings during the day and night to
help patients and clinicians understand patterns with their glucose levels and
adjusting treatment. The devices have sensors that are inserted under the skin
to monitor glucose levels continuously.
Market Dynamics:
The
China Continuous Glucose Monitoring Devices Market is expected to
witness significant growth over the forecast period, owing to rising prevalence
of diabetes in China. According to the World Health Organization, there were
around 116 million adults with diabetes in China in 2021, making it the most
affected country in the world. Growing diabetic population increases demand for
glucose monitoring devices to manage the condition. Technological advancements
in CGM devices are also fueling market growth. Newer devices provide accurate
real-time glucose readings, smartphone connectivity for data sharing with
caregivers, and are smaller in size reducing patient discomfort. Manufacturers
are focused on developing innovative products to expand customer base in China.
SWOT Analysis
Strengths:
- Growing diabetic population in China requiring glucose monitoring.
- Increasing healthcare expenditures and supportive government policies driving
market growth.
- Technological advancements enabling development of miniaturized and portable
continuous glucose monitoring devices.
Weaknesses:
- High costs of continuous glucose monitoring systems limiting widespread
adoption.
- Lack of reimbursement policies for CGMs in many regions of China.
Opportunities:
- Untapped rural regions in China presenting new growth opportunities.
- Rising awareness about benefits of continuous glucose monitoring for better
diabetes management.
Threats:
- Strong competition from alternative self-monitoring blood glucose devices.
- Stringent regulatory requirements for new product approval delaying market
entry.
Key Takeaways
The global China Continuous Glucose Monitoring Devices market is expected
to witness high growth, exhibiting CAGR
of 22.8% over the forecast period, due to increasing prevalence of diabetes
and growing healthcare expenditure in China.
Regional analysis:
The China region currently dominates the continuous glucose monitoring
devices market, capturing over 60% of the share in 2023. Rising geriatric
population, improving access to healthcare facilities and growing adoption of
advanced diabetes management solutions are driving the growth of CGM devices
market in China.
Key players:
Key players operating in the China Continuous Glucose Monitoring Devices
market are Medtronic PLC, Abbott Laboratories, Medtrum Technologies, Inc.,
Senseonics, Nemaura, Microchip Technology Inc., STMicroelectronics, NXP
Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited,
GE Healthcare, Renesas Electronics Corporation, and Toshiba Corporation.
Read
More:
https://www.dailyprbulletin.com/china-continuous-glucose-monitoring-devices-market-trends/
Comments
Post a Comment